Filing Details
- Accession Number:
- 0001437749-24-036349
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-11-27 17:06:15
- Reporting Period:
- 2024-11-25
- Accepted Time:
- 2024-11-27 17:06:15
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1855175 | Contineum Therapeutics Inc. | CTNM | Pharmaceutical Preparations (2834) | 271467257 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1861550 | S. Daniel Lorrain | 3565 General Atomics Court, Suite 200 San Diego CA 92121 | Chief Scientific Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Class A Common Stock | Disposition | 2024-11-25 | 1,010 | $16.02 | 168,562 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Class A Common Stock | 3,898 | Indirect | By Spouse |
Footnotes
- This transaction was effected pursuant to a 10b5-1 trading plan adopted by the reporting person on August 19, 2024.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $16.00 to $16.14, inclusive. The reporting person undertakes to provide to Issuer, any security holder of Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4.
Billionaire Hedge Funds
